| 673408 |
DRUG DESIGN, DEVELOPMENT AND THERAPY |
Immunomodulatory Effect of a New Ingredients Group Extracted from Astragalus Through Membrane Separation Technique |
2021-04-01 |
10.2147/dddt.s309422 |
Zhang Di, Guo Ya-Fei, Wang Ying-Li |
| 673407 |
DRUG DESIGN, DEVELOPMENT AND THERAPY |
Establishment and Verification of UPLC-MS/MS Technique for Pharmacokinetic Drug–Drug Interactions of Selinexor with Posaconazole in Rats |
2021-04-01 |
10.2147/dddt.s303928 |
Zhou Chen-jian, Wang Hui-jun, Zhou Chun-yan, Li Chao-fan, Zhu Ming-Jia, Qiu Xiang-jun |
| 673406 |
DRUG DESIGN, DEVELOPMENT AND THERAPY |
MYC/NBS1-Mediated DNA Damage Response is Involved in the Inhibitory Effect of Hydroxysafflor Yellow A on Glioma Cells |
2021-04-01 |
10.2147/dddt.s288841 |
Tang Dongfang, Huang Tao, Tian Qilong, Wang Julei |
| 673405 |
DRUG DESIGN, DEVELOPMENT AND THERAPY |
Active-Ingredient Screening and Synergistic Action Mechanism of Shegan Mixture for Anti-Asthma Effects Based on Network Pharmacology in a Mouse Model of Asthma |
2021-04-01 |
10.2147/dddt.s288829 |
Ye Qing, Zhang Qiqiang, Yao Huijuan, Xu Ajing, Liu Yan, Qi Jia, Zhang Hai, Zhang Jian |
| 673404 |
DRUG DESIGN, DEVELOPMENT AND THERAPY |
Integrating Network Pharmacology and Experimental Validation to Decipher the Mechanism of Action of Huanglian Jiedu Decoction in Treating Atherosclerosis |
2021-04-01 |
10.2147/dddt.s304911 |
Liang Jiahua, Huang Yingjie, Mai Zhexing, Zhan Qunzhang, Lin Hengchen, Xie Yuxin, Wang Haihao, Liu Yan, Luo Chuanjin |
| 673403 |
DRUG DESIGN, DEVELOPMENT AND THERAPY |
OSU-03012 Disrupts Akt Signaling and Prevents Endometrial Carcinoma Progression in vitro and in vivo |
2021-04-01 |
10.2147/dddt.s304128 |
Ding Leilei, Ren Chenchen, Yang Li, Wu Zimeng, Li Feiyan, Jiang Dongyuan, Zhu Yuanhang, Lu Jie |
| 673402 |
DRUG DESIGN, DEVELOPMENT AND THERAPY |
Population Pharmacokinetics and Safety of Oral Tetra-Arsenic Tetra-Sulfide Formula in Pediatric Acute Promyelocytic Leukemia |
2021-04-01 |
10.2147/dddt.s305244 |
Zhang Li, Yang Xin-Mei, Chen Jing, Hu Lei, Yang Fan, Zhou Yue, Zhao Bei-Bei, Zhao Wei, Zhu Xiao-Fan |
| 673401 |
DRUG DESIGN, DEVELOPMENT AND THERAPY |
Amino Acid Conjugates of Aminothiazole and Aminopyridine as Potential Anticancer Agents: Synthesis, Molecular Docking and in vitro Evaluation |
2021-04-01 |
10.2147/dddt.s297013 |
Naz Shagufta, Shah Fawad Ali, Nadeem Humaira, Sarwar Sadia, Tan Zhen, Imran Muhammad, Ali Tahir, Li Jing Bo, Li Shupeng |
| 673400 |
DRUG DESIGN, DEVELOPMENT AND THERAPY |
No Relevant Pharmacokinetic Drug–Drug Interaction Between the Sodium-Glucose Co-Transporter-2 Inhibitor Empagliflozin and Lobeglitazone, a Peroxisome Proliferator-Activated Receptor-γ Agonist, in Healthy Subjects |
2021-04-01 |
10.2147/dddt.s302215 |
Kim Yu Kyong, Hwang Jun Gi, Park Min Kyu |
| 673399 |
DRUG DESIGN, DEVELOPMENT AND THERAPY |
The Effect of Lidocaine on Postoperative Quality of Recovery and Lung Protection of Patients Undergoing Thoracoscopic Radical Resection of Lung Cancer |
2021-04-01 |
10.2147/dddt.s297642 |
Wang Lei, Sun Jing, Zhang Xueguang, Wang Guanglei |
